News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,064 Results
Type
Article (39314)
Company Profile (247)
Press Release (651503)
Section
Business (203990)
Career Advice (2002)
Deals (35401)
Drug Delivery (89)
Drug Development (80924)
Employer Resources (169)
FDA (16123)
Job Trends (14822)
News (344814)
Policy (32468)
Tag
Academia (2531)
Alliances (49291)
Alzheimer's disease (1304)
Approvals (16093)
Artificial intelligence (185)
Bankruptcy (354)
Best Places to Work (11624)
Biotechnology (175)
Breast cancer (216)
Cancer (1605)
Cardiovascular disease (123)
Career advice (1668)
Cell therapy (326)
Clinical research (65080)
Collaboration (616)
Compensation (332)
COVID-19 (2556)
C-suite (144)
Data (1519)
Diabetes (197)
Diagnostics (6239)
Earnings (85154)
Employer resources (146)
Events (110577)
Executive appointments (532)
FDA (16951)
Funding (559)
Gene therapy (224)
GLP-1 (636)
Government (4353)
Healthcare (18743)
Infectious disease (2658)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16429)
Job creations (3626)
Job search strategy (1419)
Layoffs (430)
Legal (7878)
Lung cancer (238)
Manufacturing (223)
Medical device (13247)
Medtech (13252)
Mergers & acquisitions (19291)
Metabolic disorders (519)
Neuroscience (1691)
NextGen: Class of 2025 (6508)
Non-profit (4474)
Northern California (1944)
Obesity (295)
Opinion (190)
Parkinson's disease (114)
Patents (138)
People (56737)
Phase I (20262)
Phase II (28665)
Phase III (21351)
Pipeline (651)
Postmarket research (2562)
Preclinical (8562)
Radiopharmaceuticals (240)
Rare diseases (304)
Real estate (5894)
Regulatory (21843)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1681)
Startups (3568)
United States (17406)
Vaccines (598)
Weight loss (201)
Date
Today (154)
Last 7 days (596)
Last 30 days (2815)
Last 365 days (34674)
2025 (2948)
2024 (35217)
2023 (40076)
2022 (51174)
2021 (55713)
2020 (54087)
2019 (46542)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (715)
Arizona (206)
Asia (37444)
Australia (6119)
California (4452)
Canada (1621)
China (371)
Colorado (202)
Connecticut (211)
Europe (80223)
Florida (645)
Georgia (156)
Illinois (440)
Indiana (249)
Maryland (703)
Massachusetts (3430)
Michigan (190)
Minnesota (325)
New Jersey (1260)
New York (1279)
North Carolina (804)
Northern California (1944)
Ohio (164)
Pennsylvania (1039)
South America (1093)
Southern California (1681)
Texas (648)
Utah (131)
Washington State (440)
691,064 Results for "cortexyme inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cortexyme Announces Agreement to Acquire Novosteo
Cortexyme, Inc. today announced that it entered into an agreement under which the company plans to acquire Novosteo, a privately-held biotech company focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury.
May 10, 2022
·
7 min read
Deals
Cortexyme Successfully Completes Acquisition of Novosteo
Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company developing therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the completion of its acquisition of Novosteo, a privately-held biotech company focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury.
May 20, 2022
·
3 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Business
Cortexyme Appoints June Bray to its Board of Directors
Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray, a pharmaceutical industry veteran and global drug development and regulatory process expert, to the company’s Board of Directors.
June 13, 2022
·
2 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Business
Cortexyme Announces Pipeline Update and Anticipated 2022 Milestones
Cortexyme, Inc. today provided a business update and announced key milestones for 2022.
February 1, 2022
·
9 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Biotech Bay
Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022
Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022.
July 27, 2022
·
2 min read
Business
Cortexyme Shuffles Executive Leadership Following Clinical Hold
Cortexyme, Inc. announced changes to its leadership team, including appointing Christopher Lowe as interim chief executive officer.
February 1, 2022
·
3 min read
·
Mark Terry
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
1 of 69,107
Next
